Ambler, PA, United States of America

George Ireland Poos

This inventor holds 1 USPTO granted patent. Top assignee: Mcneil Laboratories, Incorporated. Active years: 1976.

IDiyas Innovation Intelligence. (2026). Inventor Profile: George Ireland Poos. Retrieved from https://idiyas.com/inventor/george-ireland-poos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 1976

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of George Ireland Poos

Introduction

George Ireland Poos is an accomplished inventor based in Ambler, Pennsylvania. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anti-anginal properties. His work has the potential to impact the treatment of angina, a condition characterized by chest pain due to reduced blood flow to the heart.

Latest Patents

George Ireland Poos holds a patent for the invention titled "Anti-anginal activity of 2-aralkylimino-azepines - Anti-anginal activity of certain 2-aralkylimino-hexahydro-1-R.sub.1 -2H-azepines and pharmaceutical compositions thereof." This patent highlights his innovative approach to creating new pharmaceutical compositions that may improve the quality of life for patients suffering from angina.

Career Highlights

Throughout his career, George has been associated with McNeil Laboratories, Incorporated, where he has contributed to various research and development projects. His expertise in pharmacology and chemistry has enabled him to explore new avenues for drug development, particularly in cardiovascular health.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

George Ireland Poos is a notable inventor whose work in anti-anginal pharmaceuticals showcases his dedication to improving healthcare. His patent reflects a commitment to innovation that may benefit many patients in need of effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…